Prolonged disease-free survival and overall survival with CVP alternating with fludarabine in advanced follicular lymphoma

Am J Hematol. 2011 Jun;86(6):515-8. doi: 10.1002/ajh.22017. Epub 2011 Apr 27.
No abstract available

Publication types

  • Clinical Trial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / toxicity
  • Cyclophosphamide / administration & dosage
  • Disease-Free Survival
  • Humans
  • Immunotherapy, Active
  • Lymphoma, Follicular / complications
  • Lymphoma, Follicular / drug therapy*
  • Lymphoma, Follicular / mortality
  • Middle Aged
  • Prednisone / administration & dosage
  • Treatment Outcome
  • Vidarabine / administration & dosage
  • Vidarabine / analogs & derivatives*
  • Vidarabine / toxicity
  • Vincristine / administration & dosage
  • Young Adult

Substances

  • Vincristine
  • Cyclophosphamide
  • Vidarabine
  • fludarabine
  • Prednisone

Supplementary concepts

  • COP protocol 2